Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

PCSK9 Add-On Study Helps Esperion Cover All The Bases With Bempedoic Acid

Mar 27 2018

• By Emily Hayes

Cholesterol Meter

Related Content

Outcomes Claim May Help Amgen Make Case For PCSK9 Inhibitor Repatha

Dec 02 2017

Can Cholesterol Drug Sponsors Make The Case For Statin Intolerance?

Apr 21 2017

PCSK9 Turning Point? Sanofi/Regeneron Dangle Lower Price Carrot For Praluent

Mar 13 2018

Esperion's Oral Bempedoic Acid Passes First Phase III Cholesterol Test

Mar 08 2018

Related Companies

Esperion Therapeutics, Inc.

Amgen, Inc.

Merck & Co., Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Additional Topics

Clinical Trials Research & Development Cardiovascular BioPharmaceutical

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window